32 results on '"Kottke-Marchant, Kandice"'
Search Results
2. Issues Surrounding Age-Adjusted d-Dimer Cutoffs That Practicing Physicians Need to Know When Evaluating Patients With Suspected Pulmonary Embolism
3. Reducing Duplicate Testing: A Comparison of Two Clinical Decision Support Tools
4. In vivo evaluation of biomimetic fluorosurfactant polymer-coated expanded polytetrafluoroethylene vascular grafts in a porcine carotid artery bypass model
5. USE OF INTERPRETIVE SOFTWARE IMPROVES TURNAROUND TIME AND DATA ENTRY FOR COMPLEX COAGULATION TESTING IN A HIGH VOLUME LABORATORY: O23
6. Duplicate Laboratory Test Reduction Using a Clinical Decision Support Tool
7. Algorithmic Approaches to Hemostasis Testing
8. Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers
9. CLINICOPATHOLOGIC CHARACTERISTICS OF POSITIVE AND INDETERMINATE LUPUS ANTICOAGULANT TESTING IN CHILDREN: 220
10. MEASUREMENT OF ADAMTS13 ACTIVITY AND INHIBITOR: COMPARISON OF COMMERCIALLY AVAILABLE FRET ASSAYS: 223
11. CHALLENGES AND STRATEGIES FOR IMPLEMENTING AN INTERPRETIVE HEMOSTASIS SERVICE: O60
12. Loci influencing blood pressure identified using a cardiovascular gene-centric array
13. Response to Letter Regarding Article “Clinical Outcomes Using a Platelet Function-Guided Approach for Secondary Prevention in Patients With Ischemic Stroke or Transient Ischemic Attack”
14. Clinical Outcomes Using a Platelet Function-Guided Approach for Secondary Prevention in Patients With Ischemic Stroke or Transient Ischemic Attack
15. The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study
16. CLINICOPATHOLOGIC CHARACTERISTICS OF ACQUIRED VON WILLEBRAND SYNDROME: PM123
17. PERFORMANCE EVALUATION OF ASSAY APPLICATIONS ON SYSMEX®CS-2000I COAGULATION SYSTEM ANALYZER*: PM112
18. P2RY1 AND P2RY12 POLYMORPHISMS AND RESIDUAL PLATELET REACTIVITY IN CORONARY ARTERY DISEASE PATIENTS ON ASPIRIN: AM93
19. Accuracy and reliability of point-of-care platelet assays in hemodialysis patients
20. Testing for Anti-Platelet Drug Resistance - When and How to Do It and How to Report It: #51
21. Stability of Platelet Reactivity In Response To Dual Anti-Platelet Therapy In Patients Undergoing Percutaneous Coronary Intervention: 18
22. Management of patients with aspirin and clopidogrel impaired response
23. Development and validation of an array-based molecular assay for prothrombin gene mutation 20209C > T: 47
24. Assessment of aspirin and clopidogrel effect by ex vivo platelet aggregation assay: 17
25. External Peer Review Quality Assurance Testing in von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing Program
26. The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple Myeloma
27. Simultaneous Deep Venous Thrombosis and Acquired Factor VIII Inhibitor
28. The ultegra rapid platelet-function assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy
29. Monitoring Anticoagulation Therapy in Patients with the Lupus Anticoagulant
30. Coagulation markers and outcomes in acute coronary syndromes
31. BIOCOMPATIBILITY OF HEPARIN-COATED EXTRACORPOREAL BYPASS CIRCUITS: A RANDOMIZED, MASKED CLINICAL TRIAL
32. The Authors’ Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.